Click a link below to view the mailing archive as if it had been sent to you.
| 2024-11-28 00:15 | | Big pharma pushes Trump team to ease Medicare drug price negotiation rules and more... |
| 2024-11-27 12:15 | | Most life sciences CEOs expect to grow their head counts over the next 3 years: KPMG survey and more... |
| 2024-11-27 00:15 | | Novartis plots more than 100 layoffs in New Jersey as part of rework to Xolair, cancer combo field sales teams and more... |
| 2024-11-26 12:15 | | Roche to buy cell therapy developer Poseida for $1B and more... |
| 2024-11-25 12:15 | | Pfizer led industrywide sales surge in Q3 after several quarters of dominance by Eli Lilly, Novo Nordisk and more... |
| 2024-11-25 00:15 | | Johns Hopkins surgeon Makary is Trump’s pick to lead FDA and more... |
| 2024-11-22 12:15 | | As J&J tries to wrap up talc litigation in the US, the company now faces class action in UK and more... |
| 2024-11-22 00:15 | | Flagship-backed Sonata says sayonara to CEO, trims crew by 20 staffers and more... |
| 2024-11-21 12:15 | | Novartis buys Kate Therapeutics, eyeing $55B CGT market opportunity by 2030 and more... |
| 2024-11-21 00:15 | | RFK Jr. considers upheaval to US Medicare doctors’ billing system and more... |
| 2024-11-20 12:15 | | Novo, Viking heat up MASH space with promising data at AASLD24 and more... |
| 2024-11-20 00:15 | | Pfizer loses bid to recoup $75 million left over from SEC settlement and more... |
| 2024-11-19 12:15 | | Prostate cancer: Three drug trials to watch and more... |
| 2024-11-19 00:15 | | Abbott opens new FreeStyle Libre manufacturing plant in Ireland and more... |
| 2024-11-18 12:15 | | Novartis, Ratio sign radiopharmaceutical pact to the tune of $745M biobucks and more... |
| 2024-11-18 00:15 | | Trump’s Second Term Could Turn LDT Regulation on its Head and more... |
| 2024-11-15 12:15 | | Drugmakers fall as Trump picks vaccine skeptic RFK Jr for health job and more... |
| 2024-11-15 00:15 | | With RFK Jr. appointment for HHS, biopharma industry could face powerful adversary in government and more... |
| 2024-11-14 12:15 | | Eli Lilly’s weight-loss drug helps nearly 99% of patients remain diabetes-free and more... |
| 2024-11-14 00:15 | | BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink and more... |
| 2024-11-13 12:15 | | BioNTech to buy Biotheus, gaining control of cancer bispecific and more... |
| 2024-11-13 00:15 | | Merck, AstraZeneca report positive data for Koselugo in adults and more... |
| 2024-11-12 12:15 | | Pfizer explores sale of hospital drugs unit and more... |
| 2024-11-12 00:15 | | 23andMe Cuts 40% of Its Workforce, Discontinues All Therapy Programs and more... |
| 2024-11-11 12:15 | | Autolus enters CAR-T race with FDA approval for Aucatzyl and more... |
| 2024-11-11 00:15 | | GSK calls it quits on trade group BIO for 2025, following exits by Takeda, UCB and more and more... |
| 2024-11-08 12:15 | | Pfizer makes $1B commitment in China to boost innovation, targets Chinese market and more... |
| 2024-11-08 00:15 | | 12 states promised to open the books on their opioid settlement funds and more... |
| 2024-11-07 12:15 | | Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold and more... |
| 2024-11-07 00:15 | | AstraZeneca's China chief in custody, believes unrelated to insurance probe and more... |
| 2024-11-06 12:15 | | Novo Nordisk Q3 earnings: Wegovy sales soar 79% year-over-year and more... |
| 2024-11-06 00:15 | | Moderna CEO Bancel steps down and more... |
| 2024-11-05 12:15 | | Election 2024: Where do Harris and Trump stand on health policy? and more... |
| 2024-11-05 00:15 | | Election spotlight: As Harris and Trump face off, what's at stake for pharma? and more... |
| 2024-11-04 12:15 | | AstraZeneca says experimental obesity pill safe and tolerable in early-stage trial and more... |
| 2024-11-04 00:15 | | Essa abandons sole clinical-stage drug after falling short against Xtandi in phase 2 trial and more... |
| 2024-11-01 12:15 | | Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win and more... |
| 2024-11-01 00:15 | | Gardasil's China troubles haunt Merck in Q3, with execs warning of more obstacles ahead and more... |
